Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy.
about
Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma.Diffuse granulomatous panniculitis associated with anti PD-1 antibody therapy.Dermatologic Reactions to Immune Checkpoint Inhibitors : Skin Toxicities and Immunotherapy.Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade: Clinicopathologic Analysis of the Nonlichenoid Histologic Pattern.Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patients.Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients.Pulmonary Sarcoidosis Activation following Neoadjuvant Pembrolizumab plus Chemotherapy Combination Therapy in a Patient with Non-Small Cell Lung Cancer: A Case Report.Thoracic and cutaneous sarcoid-like reaction associated with anti-PD-1 therapy: longitudinal monitoring of PD-1 and PD-L1 expression after stopping treatment.Autoimmune Granulomatous Inflammation of Lacrimal Glands and Axonal Neuritis Following Treatment With Ipilimumab and Radiation TherapySarcoid-Like Granulomatosis Induced by Nivolumab Treatment in a Lung Cancer Patient
P2860
Q41864007-2C25E6DD-E221-4CAB-9BDD-678C85B63F17Q47099115-4B4C36E0-200A-46F8-9AB5-82DA8AE91051Q47277879-F845F451-473C-49E9-B531-510CE568020EQ47940731-217A02EC-0B9E-4F58-B13E-A8F00BDCCCBBQ48355954-BB62C3B5-AB2A-4165-8D17-646FCADEB777Q49305875-C9D355D2-CB34-4CF2-A202-EB91522AA396Q52668433-9A3ED490-28C2-4DBF-A53A-BF6AD6BD1FB4Q55324018-7A17DE4E-93B5-4EE8-867B-14058E8D32AFQ56889554-80A27E42-782D-4155-9DFA-D481C5DE6476Q57168689-DFD99133-7ED4-4D09-A7B6-9348B5DC5EF5
P2860
Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy.
@en
type
label
Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy.
@en
prefLabel
Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy.
@en
P2093
P2860
P1433
P1476
Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy
@en
P2093
Anne Chiang
Christopher G Bunick
Kathleen C Suozzi
Mark D Siegel
Maximilian Stahl
Scott N Gettinger
P2860
P304
P356
10.1016/J.JDCR.2016.05.002
P577
2016-05-01T00:00:00Z